Trial Profile
Pilot trial to determine the efficacy of secukinumab in active non-segmental vitiligo
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Feb 2023
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 02 Mar 2018 Status changed from recruiting to completed.
- 14 Jul 2016 New trial record